focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 52.60
Bid: 52.60
Ask: 52.80
Change: 1.90 (3.75%)
Spread: 0.20 (0.38%)
Open: 50.90
High: 53.10
Low: 50.60
Prev. Close: 50.70
IPO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

13 Mar 2023 09:00

RNS Number : 6672S
IP Group PLC
13 March 2023
 

FOR RELEASE ON

13 March 2023

IP Group - Director/PDMR share purchases

IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), which invests in breakthrough science and innovation companies with the potential to create a better future for all, has been notified that on 09 March 2023, Greg Smith, Chief Executive Officer, David Baynes, Chief Financial and Operating Officer, and Lady Flint, the wife of Sir Douglas Flint, Chairman, purchased a total of 35,052, 35,068 and 46,000 Shares of 2p each respectively as outlined in the below table.

 

Name

Title

Number of shares acquired

Price per share

Resulting beneficial interest in shares*

Resulting beneficial interest as a percentage of the Company's issued share capital

Greg Smith

Chief Executive Officer

35,052

57.1p

600,587

0.056%

David Baynes

Chief Financial and Operating Officer

35,068

56.7p

545,121

0.051%

Lady Fiona Flint

(PCA of Sir Douglas Flint)

46,000

58.4p

94,500**

0.009%**

* Where relevant, beneficial interest in shares includes shares that are subject to award under the Company's Long Term Incentive Plan which have vested by reference to performance conditions, but which remain subject to a holding period and thus have not yet been formally issued. 153,315 shares have been included for Mr Smith and 153,315 shares for Mr Baynes, which represents the total number of shares subject to such awards net of an assumed tax rate of 47%.

** Total beneficial interest of Sir Douglas Flint, Chairman and Lady Fiona Flint

 

 

The notification below, made in accordance with the requirements of article 19 of the UK Market Abuse Regulation, provides further detail.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Greg Smith

2

Reason for the notification

a)

Position/status

 Chief Executive Officer

 

b)

Initial notification/Amendment

Initial Announcement

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

IP Group plc

b)

LEI

213800HG22UM138WFG43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 2p each in IP Group plc

 

ISIN: GB00B128J450

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 

30,655

4,397

 

57.1p

56.9p

 

 

d)

Aggregated information

- Aggregated volume

- Price

Not applicable - single transaction

35,052

57.07 pence per share

e)

Date of the transaction

09 March 2023

f)

Place of the transaction

London Stock Exchange, Main Market

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

David Baynes

2

Reason for the notification

a)

Position/status

 Chief Financial and Operating Officer

 

b)

Initial notification/Amendment

Initial Announcement

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

IP Group plc

b)

LEI

213800HG22UM138WFG43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 2p each in IP Group plc

 

ISIN: GB00B128J450

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 56.67 pence per share

35,068

 

d)

Aggregated information

- Aggregated volume

- Price

Not applicable - single transaction

e)

Date of the transaction

09 March 2023

f)

Place of the transaction

London Stock Exchange, Main Market

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Lady Fiona Flint

2

Reason for the notification

a)

Position/status

 PCA of Sir Douglas Flint, Chairman

 

b)

Initial notification/Amendment

Initial Announcement

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

IP Group plc

b)

LEI

213800HG22UM138WFG43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 2p each in IP Group plc

 

ISIN: GB00B128J450

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 58.4 pence per share

46,000

 

d)

Aggregated information

- Aggregated volume

- Price

Not applicable - single transaction

e)

Date of the transaction

09 March 2023

f)

Place of the transaction

London Stock Exchange, Main Market

 

For more information, please contact:

IP Group plc

www.ipgroupplc.com

Greg Smith, Chief Executive Officer

David Baynes, Chief Financial and Operating Officer

Liz Vaughan-Adams, Communications

+44 (0) 20 7444 0050

 

+44 (0) 20 7444 0062/+44 (0) 7967 312125

Portland

Vic Wallin

Alex Donaldson

+44 (0) 7973 823119

+44 (0) 7516 729702

 

Notes for editors

 

About IP Group

 

IP Group accelerates the impact of science for a better future. Athe most active UK based, early stage science investorwe develop and support some of the world's most exciting businesses in deeptech, life sciences and cleantech (led by Kiko Ventures). Through Parkwalk, the UK's largest growth EIS fund manager, we also back world-changing innovation emerging in leading universities and research institutionsOur specialist investment team combines sector expertise with an international approach. Together we have a strong track record of success, having backed high-profile companies including Oxford Nanopore Technologies plc, First Light Fusion, Hysata, and Oxbotica. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

 

For more information, please visit our website at www.ipgroupplc.com.

 

ENDS

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGPUUGWUPWPWP
Date   Source Headline
9th Jan 20245:13 pmRNSTransaction in Own Shares
8th Jan 20245:20 pmRNSTransaction in Own Shares
5th Jan 20245:02 pmRNSTransaction in Own Shares
4th Jan 20245:48 pmRNSTransaction in Own Shares
4th Jan 20247:00 amRNSTransaction in Own Shares
3rd Jan 20247:00 amRNSTransaction in Own Shares
2nd Jan 20247:00 amRNSTotal Voting Rights
22nd Dec 20237:10 amRNSTop 20 portfolio company funding round
20th Dec 20236:20 pmRNSTransaction in Own Shares
19th Dec 20235:44 pmRNSTransaction in Own Shares
18th Dec 20237:00 amRNSShare buyback programme
14th Nov 20237:11 amRNSAutifony signs deal with Jazz for up to $770m
26th Oct 20236:10 pmRNSHolding(s) in Company
12th Oct 202310:20 amRNSWebinar on ESG & Impact
28th Sep 20234:28 pmRNSDirector/PDMR Shareholding; SAYE scheme
8th Aug 202310:00 amRNSTechnology trends webinar on AI
2nd Aug 20237:00 amRNSIP Group half-yearly results
13th Jul 20235:11 pmRNSDirector Declaration
12th Jul 20231:41 pmRNSTR-1: form for notification of major holdings
30th Jun 202310:23 amRNSTotal Voting Rights
29th Jun 20236:24 pmRNSDirector/PDMR Shareholding
28th Jun 202311:31 amRNSNotice of Results
26th Jun 202312:41 pmRNSDirector Declaration
15th Jun 20231:19 pmRNSResult of AGM
15th Jun 20237:00 amRNSAGM Statement
8th Jun 20238:51 amRNSLife Sciences update event
7th Jun 202311:00 amRNSIP Group plc - TR1 form
31st May 20232:34 pmRNSTotal Voting Rights
12th May 20231:26 pmRNSDirector Declaration
10th May 202312:11 pmRNSDirector/PDMR Shareholding
3rd May 202310:56 amRNSDirector Declaration
28th Apr 20233:21 pmRNSTotal Voting Rights
20th Apr 20235:00 pmRNSNotice of AGM, Annual Report
18th Apr 20233:23 pmRNSRSP & DBSP awards; Director/PDMR shareholding
15th Mar 20239:31 amRNSInvestor presentation
13th Mar 20239:00 amRNSDirector/PDMR Shareholding
13th Mar 20237:00 amRNSNo direct deposits or credit facilities with SVB
8th Mar 20237:00 amRNSIP Group plc - Annual Results
2nd Mar 20233:25 pmRNSTR-1
21st Feb 20237:00 amRNSAMSL Aero's all-electric aircraft maiden flight
10th Feb 20239:55 amRNSNotice of Results
31st Jan 202310:00 amRNSTotal Voting Rights
30th Jan 20237:00 amRNSStatement re press speculation
24th Jan 20231:18 pmRNSForm 8.3 - Mirriad Advertising plc
18th Jan 20237:00 amRNSDirectorate Change
11th Jan 20237:00 amRNSPortfolio company Oxbotica raises $140m Series C
3rd Jan 202311:48 amRNSTotal Voting Rights
12th Dec 20224:58 pmRNSAGM post-meeting shareholder engagement update
7th Dec 20224:39 pmRNSHolding(s) in Company
5th Dec 20227:00 amRNSIstesso announces FDA Fast Track for MBS2320

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.